Company: ZLAB
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001628280-25-020478
Chunk: 7

Company: Zai Lab Ltd
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 7
---
     | Board Committees                    |     | Other Public Company Boards |
| 60  |     |           2014 |     | Research and Development Commercial |     | None                        |

Dr. Du is an experienced executive and entrepreneur with significant global leadership experience who brings to the Board of Directors a deep knowledge of the capital markets and the biotechnology, healthcare, and pharmaceutical

<div align='center'>-2-</div>

industries as well as a considerable scientific background. In addition, as the Company’s Founder and Chief Executive Officer, Dr. Du provides valuable knowledge of the Company and its business.

#### Key Experience and Qualifications
• Founder, Chief Executive Officer, and Chairperson of the Board of Directors of Zai Lab (2014-Present)

• Healthcare Partner (2012-2014) and Venture Partner (2014-2017) at Sequoia Capital China, leading and serving on the boards of several major healthcare investments

• Co-Founder and Chief Executive Officer of Hutchison MediPharma and Co-Founder and Chief Scientific Officer of Hutchison China MediTech (2001-2011)

• Began her research career at Pfizer Inc. in the United States, where she led the global metabolic licensing program and was involved in the development of multiple early and late-stage products (1994-2001)

• Ph.D. in Biochemistry from the University of Cincinnati and a B.S. in Molecular Biology from Jilin University, China

#### John David Diekman, Ph.D.
Lead Independent Director

| Age |     | Director Since |     | Board Committees                                                                                                    |     | Other Public Company Boards |
| 82  |     |           2017 |     | Audit                                    Compensation                           Nominating and Corporate Governance |     | None                        |

Dr. Diekman is an experienced executive who brings to the Board of Directors extensive business, management, policy, and capital markets experience as well as deep expertise in the life sciences and venture capital industries, including in the area of oncology.

#### Key Experience and Qualifications
• Founder and Managing Partner of 5AM Ventures (2002-Present)

• Chairman of the Board of Directors of IDEAYA Biosciences, Inc. (NASDAQ) (2015-June 2020)

• Chairman of The Scripps Research Institute (2014-Present), member of the Advisory Board of the Schaeffer Center for Health Policy and Economics at the University of Southern California (2014-March 2021), Charter